Skip to main content
Log in

Fluconazole therapy for Candida albicans urinary tract infections in infants

  • Clinical Nephrology
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract.

Candiduria is rare in newborns and infants, occurring most often in patients with risk factors. When associated with a candidal bezoar in the urinary tract, candiduria is usually treated by systemic amphotericin B and flucytosine plus local irrigation with amphotericin B. We describe the successful treatment of five newborns with a urinary tract infection, on major urological malformations, due to Candida albicans (including three with a candidal bezoar) by fluconazole alone. No adverse effects or recurrences were observed. Fluconazole therapy permits early discharge from the hospital and seems suitable for infants and newborns with a C. albicans urinary tract infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Triolo, V., Gari-Toussaint, M., Casagrande, F. et al. Fluconazole therapy for Candida albicans urinary tract infections in infants. Pediatr Nephrol 17, 550–553 (2002). https://doi.org/10.1007/s00467-002-0861-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-002-0861-y

Navigation